Exports In 2022, United Kingdom exported $6.05B in Vaccines, blood, antisera, toxins and cultures, making it the 12th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most exported product in United Kingdom. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United Kingdom are: United States ($2.48B), France ($514M), Japan ($318M), Germany ($314M), and Netherlands ($282M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United Kingdom between 2021 and 2022 were United States ($348M), France ($202M), and Japan ($167M).
Imports In 2022, United Kingdom imported $9.99B in Vaccines, blood, antisera, toxins and cultures, becoming the 10th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most imported product in United Kingdom. United Kingdom imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($2.72B), Germany ($1.6B), Switzerland ($1.33B), United States ($1.28B), and Ireland ($997M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United Kingdom between 2021 and 2022 were Ireland ($277M), United States ($205M), and United Kingdom ($150M).